Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Denham

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Radiation Oncology (London, England)|November 2, 2016
Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complicationsCalyn R Moulton, Michael J House, Victoria Lye, et al.
Radiation Oncology (London, England)|December 16, 2015
Registering prostate external beam radiotherapy with a boost from high-dose-rate brachytherapy: a comparative evaluation of deformable registration algorithmsCalyn R Moulton, Michael J House, Victoria Lye, et al.
BJU International|May 12, 2018
Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapyRobert U Newton, Emily Jeffery, Daniel A Galvão, et al.
Journal of Medical Imaging and Radiation Oncology|February 11, 2017
Accumulation of rectum dose-volume metrics for prostate external beam radiotherapy combined with brachytherapy: Evaluating deformably registered dose distribution addition using parameter-based additionCalyn R Moulton, Michael J House, Victoria Lye, et al.
International Journal of Radiation Oncology, Biology, Physics|October 9, 2012
Treatment-related morbidity in prostate cancer: a comparison of 3-dimensional conformal radiation therapy with and without image guidance using implanted fiducial markersJasmeet Singh, Peter B Greer, Martin A White, et al.
The Medical Journal of Australia|March 16, 2011
A magnetic resonance imaging-based workflow for planning radiation therapy for prostate cancerPeter B Greer, Jason A Dowling, Jonathon A Lambert, et al.
Cancers|August 29, 2024
CCL2/CCR2 Expression in Locally Advanced Prostate Cancer and Patient Long-Term Outcome: 10-Year Results from the TROG 03.04 RADAR TrialMark Marsland, Chen Chen Jiang, Sam Faulkner, et al.
Journal of Medical Imaging and Radiation Oncology|October 15, 2013
Effect of androgen deprivation therapy on muscle attenuation in men with prostate cancerDavid Chang, David J Joseph, Martin A Ebert, et al.
European Journal of Pharmacology|December 25, 2013
Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in ratsRobert C Wood, Jarrett E Wyatt, Kenny W Bullins, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 11, 2008
PSA response signatures - a powerful new prognostic indicator after radiation for prostate cancer?James W Denham, David S Lamb, David Joseph, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Radiation Oncology (London, England)|November 2, 2016
Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complicationsCalyn R Moulton, Michael J House, Victoria Lye, et al.
Radiation Oncology (London, England)|December 16, 2015
Registering prostate external beam radiotherapy with a boost from high-dose-rate brachytherapy: a comparative evaluation of deformable registration algorithmsCalyn R Moulton, Michael J House, Victoria Lye, et al.
BJU International|May 12, 2018
Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapyRobert U Newton, Emily Jeffery, Daniel A Galvão, et al.
Journal of Medical Imaging and Radiation Oncology|February 11, 2017
Accumulation of rectum dose-volume metrics for prostate external beam radiotherapy combined with brachytherapy: Evaluating deformably registered dose distribution addition using parameter-based additionCalyn R Moulton, Michael J House, Victoria Lye, et al.
International Journal of Radiation Oncology, Biology, Physics|October 9, 2012
Treatment-related morbidity in prostate cancer: a comparison of 3-dimensional conformal radiation therapy with and without image guidance using implanted fiducial markersJasmeet Singh, Peter B Greer, Martin A White, et al.
The Medical Journal of Australia|March 16, 2011
A magnetic resonance imaging-based workflow for planning radiation therapy for prostate cancerPeter B Greer, Jason A Dowling, Jonathon A Lambert, et al.
Cancers|August 29, 2024
CCL2/CCR2 Expression in Locally Advanced Prostate Cancer and Patient Long-Term Outcome: 10-Year Results from the TROG 03.04 RADAR TrialMark Marsland, Chen Chen Jiang, Sam Faulkner, et al.
Journal of Medical Imaging and Radiation Oncology|October 15, 2013
Effect of androgen deprivation therapy on muscle attenuation in men with prostate cancerDavid Chang, David J Joseph, Martin A Ebert, et al.
European Journal of Pharmacology|December 25, 2013
Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in ratsRobert C Wood, Jarrett E Wyatt, Kenny W Bullins, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 11, 2008
PSA response signatures - a powerful new prognostic indicator after radiation for prostate cancer?James W Denham, David S Lamb, David Joseph, et al.
Pageof 10